Tetrazolium dye (MTT) is cleaved to form formazan by metabolically active cells and exhibits a strong red absorption band at 550-618 nm. The protocol for the cell viability assay was provided by the manufacturer and modified in our laboratory as described below.
Cells were seeded in 96-well microtiter plates at a concentration of 6x10 3 for DU-145, 10x10 3 for LNCaP, 4x10 3 for MCF-7 and 12x10 3 cells for AT2780 per well, in a volume of 100 μl of cell culture medium. After 24 h, 20 ml aliquots of the compounds at various concentrations were added to the attached cells. Each concentration was plated into 3 wells to obtain mean values. To eliminate any solvent effect, 20 ml of the solvent used in the preparation of the highest concentration of the compounds (a maximum of 0.5% by volume of DMSO) was added to the control cells in each well. The plates were incubated at 37˚C in the CO 2 incubator for 72 h. At the end of day 3, the culture medium was carefully removed without disturbing the cells, and replaced by 100 μl of fresh cell medium. Ten microliters of MTT reagent was added to each well and the plates were incubated again in the CO 2 incubator at 37˚C for 4 h. SDS solublizing reagent (100 μl) (Boehringer Mannheim) was added to each well. The plate was allowed to stand overnight in the CO 2 incubator and read by ELISA Reader (EL800, Bio-Tek Instruments, Inc.) at a wavelength of 570 nm. The percent cell viability was calculated according to the equation below: 100% (absorption of the control cells -absorption of the treated cells/absorption of the control cells). By definition, the viability of the control cells, from the untreated cell cultures, was defined as 100%.
Sample preparation for cell cycle measurement. Cultured LNCaP and DU-145 (2-4x10 6 cells) cells were exposed to varying concentrations of ISL for 24 and 48 h (in 12.5 cm 2 area flask) before being harvested. The cells were washed with PBS and fixed in ice-cold 70% ethanol. Aliquots of fixed cells were re-hydrated into PBS and stained with 1.0 mg/ml DAPI (4,6-diamidino-2-phenylindole from Eastman Kodak, Rochester, NY) dissolved in 10 mM piperazine-N, N-bis-2-ethane-sulfonic acid buffer (Calbiochem, La Jolla, CA) containing 100 mM NaCl, 2 mM MgCl 2 and 0.1% Triton X-100 (Sigma) at pH 6.8.
Analysis of cell cycle distribution. Cellular DNA content, after cell staining with the DNA specific fluorochrome DAPI, was measured with an ELITE ESP flow cytometer (Coulter Inc., Miami, FL) using UV laser illumination. The Multicycle program (Phoenix Flow Systems, San Diego, CA) was used to deconvolute the DNA frequency histograms to estimate the frequency of cells in different phases of the cell cycle and in apoptosis. The experiments were repeated several times, yielding essentially identical results.
Western blot analysis of AR concentration in LNCaP.
Western blot analysis was used to measure the concentration of AR protein in LNCaP cells following growth for 48 h in the absence and presence of oridonin, ISL and wogonin. Equal amounts of protein (10 mg) from LNCaP cell lysates were applied to 10% SDS/PAGE gel, and were then transferred to PVDF membranes (actin was used as a loading control). The blots were probed with primary mouse anti-human antibodies from DAKO (1:100 anti AR) followed by a 1-h incubation with a 1:1000 dilution of the labeled secondary antibody anti-mouse IgG-HRP (Santa Cruz Biotechnology, USA). The antibody binding was detected using chemiluminescence (ECL Western blotting system). The experiments were run in duplicate.
Western blot analysis of PSA concentration in LNCaP.
Western blot analysis was used to measure the concentration of PSA protein in LNCaP cells following the growth in the absence and presence of ISL and wogonin. The protocol is similar to that for AR analysis. The blots were probed with primary mouse anti human antibodies from DAKO (1:400 anti-PSA) followed by a 1-h incubation with a 1:1500 dilution of the labeled secondary antibody, anti-mouse IgG-HRP (Santa Cruz Biotechnology). The antibody binding was detected using chemiluminescence (ECL Western blotting system). The experiments were run in duplicate.
Flow cytometric measurement of AR concentration.
Following treatment with oridonin (3-9 mM) for 48 h, the cells were trypsinized, washed with PBS, fixed in 1% formaldehyde in PBS on ice for 10 min and then permeabilized with 70% ethanol at -20˚C. After fixation, the cells were rinsed with PBS, treated with a blocking solution containing 1% (w/v) bovine serum albumin (BSA) and 0.1% sodium azide in PBS (PBS-BSA) for 2 min at room temperature. The cells were subsequently added to a 100-ml aliquot of BSA/PBS solution containing 1:50 diluted primary antibody from DAKO (mouse anti-human) for AR. The mixtures were incubated at room temperature for 1 h in the dark. The cells were subsequently washed twice with PBS-BSA buffer. The secondary antibody from DAKO conjugated to FITC (goat anti-mouse) was added at a dilution of 1:50 for 30 min at room temperature in the dark. Then cells were counterstained for DNA by 1 ml of PI solution (final PI concentration 5 mg/ ml) containing 100 μg/ml of RNase A. Cellular fluorescence was measured with the ELITE ESP flow cytometer/cell sorter using the argon ion laser (emission at 488 nm). Fluorescence signals were collected using the standard configuration of the flow cytometer (green fluorescence for antibodies against AR and red fluorescence for DNA staining). The fluorescence intensities of ten thousand cells were measured per sample.
Apoptosis induced by ISL and wogonin. The prostate cancer cells, LNCaP and DU-145, were counterstained with DNA specific fluorochrome DAPI and viewed under mixed illumination, combining UV light excitation and Nomarski interference contrast fluorescence microscope (Nikon Microphot).
Inhibition of cyclooxygenase (COX) activity by ISL.
The direct effect of ISL on the enzymatic activity of COX 1 and COX 2 was assayed following the protocol provided by the commercial assay kit from Cayman Chemical Co. (#760151). Basically, the COX activity was evaluated by utilizing the peroxidase component of cyclooxygenases. The peroxidase activity is measured colorimetrically by monitoring the appearance of oxidized N,N,N',N'-tetramethyl-p-phenylenediamine (TMPD) at 590 nm.
Results
Antiproliferative effect of ISL and wogonin on prostate cancer cell lines. The inhibitory effect of ISL and wogonin on cancer cell growth was evaluated by the MTT assay. Table I summarizes the IC 50 of the two reagents on the two prostate cancer cell lines LNCaP and DU-145. ISL and wogonin exhibited similar antiproliferative activity against LNCaP; however, the antiproliferative activity of ISL against DU-145 is about 5 times stronger than that of wogonin. The cytotoxicity effect of baicalein, baicalin and oridonin were reported previously (27) (28) (29) (30) .
Apoptosis of prostate cancer cells -changes in morphology
induced by ISL and wogonin. Fig. 1 displays the morphology of prostate cancer cell lines, LNCaP and DU-145, in the absence and presence of ISL and wogonin at concentrations of 8 μg/ml and 10 μg/ml, respectively. Mitotic figures and apoptotic cells were occasionally observed. Numerous apoptotic cells characterized by highly condensed chromatin and nuclear fragmentation are clearly seen in Fig. 1 . It is noteworthy that wogonin induced a profound apoptotic effect on both LNCaP and DU-145 notwithstanding the difference between the two cell lines in IC 50 values. Additionally, the apoptotic cell populations of the two cell lines were observed in DAPI stained cell cycle distribution following the treatment of ISL and wogonin for 48 h, respectively (data not shown).
Effect of ISL and wogonin on prostate cancer cell cycle. ISL induced differential cell cycle changes in LNCaP and DU-145 after 24 h. Fig. 2 shows the modulation of cell cycle by ISL at various concentrations at 48 h. At a relatively low concentration (4 μg/ml), ISL prolonged G 1 phase in LNCaP. However, higher concentrations of ISL (8 μg/ml) caused a G 2 M phase arrest.
Interestingly, this phenomenon was not observed in DU-145. A very significant G 2 M phase arrest in DU-145 was detected at concentrations higher than 4 μg/ml. Similar to ISL, wogonin exerted a more profound cell cycle modulation on DU-145 than on LNCaP under similar concentration. A significant G 2 M cell population of DU-145 was prolonged by the treatment of 25.8 μg/ml wogonin. While the same effect on LNCaP was negligible.
Down-regulation of androgen-receptor (AR) protein by oridonin and ISL. AR protein expression in LNCaP was
measured by Western blot analysis. Fig. 3 shows the protein levels detected following oridonin, wogonin and ISL treatment of cells. The decrease in AR protein is both concentration and time-dependent. In the presence of 15.6 μM (8 μg/ml) of ISL, the expression of AR protein was undetectable at 48 h. Similarly, there was a large decrease in AR concentration (>50%) by oridonin at 14.5 μM.
Down-regulation of androgen-receptor (AR) protein by oridonin detected by flow cytometry.
To confirm the Western blot result, flow cytometric method was used to determine Table I . Antiproliferative activity of ISL and wogonin, IC 50 , on LNCAP and DU-145. ----------------------------------------------- 
-------------------------------------------------Cell line ISL (μM) Wogonin (μM) -------------------------------------------------

ISL concentration (μg/ml)
the COX enzyme activity. Fig. 6 displays the dose response curves of ISL on COX 1 (green) and COX 2 (red). The curves were graphed using non-linear regression curve fit (Harvard graphic). It seems that ISL is slightly more sensitive towards COX 1 (IC 50 ~8 μM) than COX 2 (IC 50 ~12 μM).
Discussion
It is well established that the development and progression of prostate cancer is dependent on androgen and the AR. In as much as AR plays a complex and diversified role in prostate cancer, recent studies have demonstrated its important role in the transition of prostate cancer from the androgen dependent to independent stage (3-15). Yuan et al further showed that AR was also a critical player for cell cycle progression in androgen-independent CWR22 prostate cancer cells (31) .
The sensitization of AR signaling pathways in HRPC is caused by several factors. Using microarray-based profiling of prostate cancer xenograft models, Chen et al demonstrated that androgen receptor antagonists converted to agonistic activity in cells with increased androgen receptor levels (11) . This antagonist-agonist conversion was associated with alterations in the recruitment of coactivators and corepressors to the promoters of androgen receptor target genes. Thus, the increase in AR mRNA and protein was both necessary and sufficient to convert prostate cancer growth from a hormone-sensitive to hormone-refractory (HRPC) stage. The other contributing factor to HRPC is AR mutation. Dehm et al showed a mutation in molecular structure of AR leads HRPC cells to be independent of the ligand binding and AF-2 region. Instead, HRPC cells become N-terminal domain dependent (10) . These studies consistently demonstrate the critical function of AR in androgen-independent prostate cancer is distinct from its classical transcriptional or nontranscriptional functions.
In line with the above, results obtained from this study seem to support our previous theory that down-regulation of AR by various phyto-chemicals in PC-SPES is one of the mechanisms that contributed to its anti-HRPC activity (26) (27) (28) (29) (30) 32, 33) .
It is noted that oridonin has a very different chemical structure and physico-chemical properties compared to those of ISL, wogonin and baicalin. The latter compounds belong to the chemical group of polyphenols or flavonoids. Polyphenols extracted from many plants have been shown to be either chemopreventive or antitumor agents in a wide range of carcinogenesis models. By flow cytometric analysis, the polyphenol fraction was demonstrated to induce G 0 /G 1 cell growth arrest and cell apoptosis in DU-145 and PC-3 triggered by caspase-3 activation (34, 35) . Since oridonin (36, 37) , baicalein, wogonin (38) (39) (40) and ISL (41) are known to stimulate caspase-3 activation, the apoptosis of LNCaP and DU-145 observed in Fig. 1 was likely caused by the same mechanism.
In addition to caspase-3 activators, baicalein, wogonin, isoliquiritigenin and oridonin are also potent inhibitors of NF-κB transcriptional activity (42) (43) (44) (45) . The NF-κB family of transcription factors has been shown to be constitutively activated in various human malignancies.
An inverse correlation between androgen receptor (AR) status and NF-κB activity was observed in prostate cancer cell lines (46) (47) (48) (49) (50) (51) . The study by Suh et al showed that NF-κB promoted cell growth and proliferation in prostate cancer cells by regulating expression of genes such as c-myc, cyclin D1 and IL-6. Furthermore, NF-κB-mediated expression of genes involved in angiogenesis (IL-8, VEGF), and invasion and metastasis (MMP 9, uPA, uPA receptor) may further contribute to the progression of androgen depleted prostate cancer. In view of the above, the antiproliferative activity of these phytochemicals is partly due to their inhibitory action on the transactivation of NF-κB and to the depletion of AR.
In this study, we have also shown that ISL is a potent COX 1 and COX 2 enzyme inhibitor. These type of inhibitors (NSAIDs) have been reported to reduce prostate cancer risk due to the activarion of COX-2 gene in progressive prostate cancer (52) (53) (54) (55) (56) (57) (58) . Whether there is a direct relationship between the anti-inflammatory nature of ISL and its AR depleting activity remains to be investigated.
Finally, the depletion of PSA observed in the LNCaP cell line caused by ISL, oridonin and wogonin can be understood in terms of their ability to down-regulate AR. Since PSA gene is positively regulated via binding of AR to the androgenresponsive elements in the promoter of PSA, it is expected that reduction of AR will lead to a decline in PSA (59) (60) (61) .
Taken together, we have shown that the phyto-chemicals oridonin, ISL and wogonin exert antiproliferative activity via modulation of cell cycle. Some of these compounds down-regulate the protein expression of AR and PSA in LNCaP. In view of the potential benefit of these agents in controlling HRPC progression, more study is in progress to understand the in vitro and in vivo mechanisms.
